What if you could distinguish between on-target and off-target effects earlier in your discovery process? Too many hits are progressed into development without thorough target validation resulting in costly failed studies.
In this webinar, we’ll share ways to exploit CRISPR/Cas9 in rescue target and hit validation assays. Learn how to use this technology to improve your confidence that the target is causative for the disease and a that a putative hit compound is modulating.
Lieke Geerts, PhD
Senior Scientist, Biology, Charles River